Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
In Patients with Advanced Urothelial Carcinoma, Immune Checkpoint Inhibition Prior to Enfortumab Vedotin Is Associated with High-grade Skin Toxicity. European urology Molina, G. E., Schwartz, B., Srinivas, S., Shah, S., Zaba, L. C. 2023
View details for DOI 10.1016/j.eururo.2022.12.009
View details for PubMedID 36623949